Alan vs Butterfly Network
In-depth comparison — valuation, funding, investors, founders & more
🇫🇷 France · Jean-Charles Samuelian
Valuation
$1.4B
Total Funding
$220M
500-1000 employees
🇺🇸 United States · John Martin
Valuation
$1.5B
Total Funding
$700M
500-1000 employees
Analyst Summary
Generated from real data · No AI hallucinations
Both Alan and Butterfly Network compete directly in the AI Healthcare space, making this a head-to-head matchup within the same market segment. Alan is an AI-powered health insurance platform that combines employer group health insurance products with a digital health companion application, using AI to personalise member health recommendations, streamline claims processing, and provide on-demand access to telehealth and mental health resources. Butterfly Network produces the Butterfly iQ, a handheld ultrasound device powered by a proprietary semiconductor chip that replaces traditional piezoelectric transducer arrays with a single silicon chip capable of whole-body imaging.
Butterfly Network ($1.5B) is valued slightly higher than Alan ($1.4B). On the funding side, Butterfly Network has raised $700M in total — $480M more than Alan's $220M.
Butterfly Network has 5 years more market experience, having been founded in 2011 compared to Alan's 2016 founding. In terms of growth stage, Alan is at Series D while Butterfly Network is at Public — a meaningful difference for investors evaluating risk and upside.
Alan operates out of 🇫🇷 France while Butterfly Network is based in 🇺🇸 United States, giving each a distinct home-market advantage. On Awaira's 0–100 composite score, both companies are closely matched — Alan scores 83 and Butterfly Network scores 85.
Metrics Comparison
| Metric | Alan | Butterfly Network |
|---|---|---|
💰Valuation | $1.4B | $1.5BWINS |
📈Total Funding | $220M | $700MWINS |
📅Founded | 2016WINS | 2011 |
🚀Stage | Series D | Public |
👥Employees | 500-1000 | 500-1000 |
🌍Country | France | United States |
🏷️Category | AI Healthcare | AI Healthcare |
⭐Awaira Score | 83 | 85WINS |
Key Differences
Valuation gap: Butterfly Network is valued 1.1x higher ($1.5B vs $1.4B)
Funding gap: Butterfly Network has raised $480M more ($700M vs $220M)
Market experience: Butterfly Network has 5 years more (founded 2011 vs 2016)
Growth stage: Alan is at Series D vs Butterfly Network at Public
Market base: 🇫🇷 Alan (France) vs 🇺🇸 Butterfly Network (United States)
Direct competitors: Both operate in the AI Healthcare market segment
Awaira Score: Butterfly Network scores 85/100 vs Alan's 83/100
Which Should You Choose?
Use these signals to make the right call
Choose Alan if…
- ✓France-based for regional compliance or proximity
- ✓Alan is an AI-powered health insurance platform that combines employer group health insurance products with a digital health companion application, using AI to personalise member health recommendations, streamline claims processing, and provide on-demand access to telehealth and mental health resources
Choose Butterfly Network if…
Top Pick- ✓Higher Awaira Score — 85/100 vs 83/100
- ✓More established by valuation ($1.5B)
- ✓Stronger investor backing — raised $700M
- ✓More market experience — founded in 2011
- ✓United States-based for regional compliance or proximity
- ✓Butterfly Network produces the Butterfly iQ, a handheld ultrasound device powered by a proprietary semiconductor chip that replaces traditional piezoelectric transducer arrays with a single silicon chip capable of whole-body imaging